FDA
- Status: approved
Sublingual buprenorphine with naloxone (Sublingual buprenorphine with naloxone) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
VA Office of Research and Development is the originator. The local marketing authorisation holder may differ — check the official source linked above.